
Michael I Seider MD
Retinal Disease, Ocular Oncology
Co-director of Ocular Oncology, Vitreoretinal Surgeon - The Permanente Medical Group Assistant Clinical Professor, UCSF
Join to view full profile
10 Koret WaySan Francisco, CA 94143
Phone+1 415-476-1922
Dr. Seider is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Seider is an ophthalmologist based in San Francisco, CA, specializing in retinal disease and ocular oncology. He completed his medical education at the University of Miami Leonard M. Miller School of Medicine and has received extensive training with an internship in internal medicine, a residency in ophthalmology, and fellowships in ocular oncology and surgical retina. Dr. Seider has a full-scope surgical Retina and ocular oncology program practice. He has contributed to several publications in well-regarded journals and has been recognized with multiple awards such as the Heed Research Fellowship and the Langer OKAP Award.
Education & Training
Duke University HospitalFellowship, Surgical Retina and Vitreous, 2014 - 2016
University of California (San Francisco)Fellowship, Ocular Oncology/Ophthalmic Pathology, 2013 - 2014
University of California (San Francisco)Residency, Ophthalmology, 2010 - 2013
Huntington Memorial HospitalInternship, Internal Medicine, 2009 - 2010
University of Miami Leonard M. Miller School of MedicineClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2028
NC State Medical License 2014 - 2016
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2016
- Heed Research Fellowship The Heed Foundation, 2014
- Patient Care Fund Award University of California, San Francisco, 2014
Publications & Presentations
PubMed
- 2 citationsLong-Term Clinical Outcomes for Adolescent and Young-Adult Uveal Melanoma Patients Treated with Dedicated Particle-Beam Radiation.Carly Zako, Arina Nisanova, Vivian Weinberg, Jessica Scholey, Carisa Swason
Cancers. 2025-06-19 - 1 citationsMassage Gun Ophthalmopathy.Michael I Seider, Cindy S Hwang
Ophthalmology. 2023-10-01 - 10 citationsPrognostic Value of BAP1 and Preferentially Expressed Antigen in Melanoma (PRAME) Immunohistochemistry in Uveal Melanomas.Lucy M Han, Kar Wan Lee, Gunay Uludag, Michael I Seider, Armin R Afshar
Modern Pathology. 2023-04-01
Journal Articles
- Uveal melanoma gene expression profile test provided for uveal metastasisSeider MI, Stewart PJ, Mishra KK, Damato BE, Ophthalmic Surg Lasers Imaging Retina, 8/1/2014
- Cost of Phacovitrectomy Versus Vitrectomy then Sequential PhacoemulsificationSeider MI, Lahey JM, Fellenbaum PS, Retina, 1/1/2014
- The association between compliance with recommended follow-up and glaucomatous disease severity in a county hospital populationUng C, Murakami Y, Zhang E, Alfaro T, Zhang M, Seider MI, Singh K, Lin SC, American Journal of Ophthalmology, 1/1/2013
Abstracts/Posters
- Case presentation: Iris melanoma with angle seeding treated with iridocyclectomy.Seider MI, Damato BE, International Society of Ocular Oncology, Cleveland, 10/1/2013
- "An Electronic Tool for Retinoblastoma Diagnosis"Seider MI, Damato BE, International Society of Ocular Oncology, Cleveland, 10/1/2013
- "The effect of procedure room temperature and humidity on LASIK outcomes"Seider MI, McLeod SD, Schallhorn SC, ARVO Annual Meeting, Seattle, 5/1/2013
Authored Content
- Current Imaging Techniques for Intraocular TumorsJanuary 2019
- Current Imaging Techniques for Intraocular TumorsJanuary 2019
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









